Emanuele Puca

9PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 21, 2026
Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot.

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

|Sep 11, 2025
Past, present and future of drug conjugates for cancer therapy.

S Cazzamalli, E Puca, D Neri

|Apr 19, 2024
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer.

Abdullah Elsayed, Louis Plüss, Larissa Nideroest

|Jun 08, 2023
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.

Abdullah Elsayed, Christian Pellegrino, Louis Plüss

|May 27, 2023
Generation and <i>in vivo</i> characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen.

Louis Plüss, Frederik Peissert, Abdullah Elsayed

Pageof 2

Frequent Collaborators

8 joint publications

Dario Neri

5 joint publications

Abdullah Elsayed

4 joint publications

Roberto De Luca

3 joint publications

Samuele Cazzamalli